ClinicalTrials.Veeva

Menu

Vaginal Clindamycin Cream Plus Vaginal Probiotic for Bacterial Vaginosis

Z

Zagazig University

Status and phase

Unknown
Phase 2

Conditions

Bacterial Vaginosis Treatment

Treatments

Drug: Vaginal Probiotic
Drug: Vaginal Clindamycin Cream

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Vaginal Clindamycin Cream Plus Vaginal probiotic for treatment of Bacterial Vaginosis

Full description

Vaginal Clindamycin Cream was used initially for treatment of Bacterial Vaginosis followed by Vaginal probiotic either in cnotinous or interrupted manner, then assessment of the results of treatment at different time intervals was done.

Enrollment

200 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • more than 18 years
  • has recurrent Bacterial Vaginosis

Exclusion criteria

  • pregnancy
  • use of other antmicrobial
  • not provide informed consent

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

200 participants in 2 patient groups

Vaginal Clindamycin Cream Plus continuous Vaginal Probiotic
Experimental group
Description:
Vaginal Clindamycin Cream followed by continuous Vaginal Probiotic use for 60 days
Treatment:
Drug: Vaginal Clindamycin Cream
Drug: Vaginal Probiotic
Vaginal Clindamycin Cream Plus interrupted Vaginal Probiotic
Active Comparator group
Description:
Vaginal Clindamycin Cream followed by interrupted Vaginal Probiotic use
Treatment:
Drug: Vaginal Clindamycin Cream
Drug: Vaginal Probiotic

Trial contacts and locations

1

Loading...

Central trial contact

Mohamed L Elsayed; Ibrahim A EL sharkwy

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems